Literature DB >> 34971456

Propofol context-sensitive decrement times in children.

James D Morse1, Luis Ignacio Cortinez2, Stephen Meneely3, Brian J Anderson4.   

Abstract

Plasma drug concentration is the variable linking dose to effect. The decrement time required for plasma concentration of anesthetic agents to decrease by 50% (context-sensitive half-time) correlates with the time taken to regain consciousness. However, the decrement time to consciousness may not be 50%. An effect compartment concentration is associated more closely with return of consciousness than plasma concentration. An alternative decrement time, the time required for propofol to decrease to a predetermined effect compartment concentration associated with movement (eg, 2 µg.ml-1 ), was used to simulate time for the concentration to decrease from steady state at a typical targeted effect compartment concentration 3.5 µg.ml-1 in children. These times were short and reflected a decrement time to consciousness (CSTAWAKE ) increase that was small with longer infusion time. CSTAWAKE ranged from 7.5 min in 1-year-old infant given propofol for 15 min to 13.5 min in a 15-year-old adolescent given a 2-hour infusion. Changes in decrement time with age reflect maturation of drug clearance. Neonates had prolonged increment times, 10 min after 15 min infusion and 18 min after 120 min infusion using a target concentration of 3.5 µg.ml-1 . Decrement times to a targeted arousal concentration are context-sensitive. Use of a higher target concentration of 6 µg.ml-1 doubled decrement times. Decrement times are associated with variability: delayed recovery beyond these simulated times is likely more attributable to the use of adjuvant drugs or the child's clinical status. An understanding of propofol decrement times can be used to guide recovery after anesthesia.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  anesthesia; infusion; intravenous; pediatrics; pharmacokinetics; propofol; total intravenous anesthesia

Mesh:

Substances:

Year:  2022        PMID: 34971456     DOI: 10.1111/pan.14391

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  2 in total

Review 1.  Pharmacokinetic Pharmacodynamic Modelling Contributions to Improve Paediatric Anaesthesia Practice.

Authors:  James D Morse; Luis Ignacio Cortinez; Brian J Anderson
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

Review 2.  Interactions of the protease inhibitor, ritonavir, with common anesthesia drugs.

Authors:  Anders Svedmyr; Henrik Hack; Brian J Anderson
Journal:  Paediatr Anaesth       Date:  2022-07-24       Impact factor: 2.129

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.